These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25107829)

  • 1. Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users.
    Uosukainen H; Tacke U; Winstock AR
    Int J Drug Policy; 2015 Jan; 26(1):78-83. PubMed ID: 25107829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mephedrone, new kid for the chop?
    Winstock AR; Mitcheson LR; Deluca P; Davey Z; Corazza O; Schifano F
    Addiction; 2011 Jan; 106(1):154-61. PubMed ID: 20735367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
    Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
    Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.
    Wu LT; Schlenger WE; Galvin DM
    Drug Alcohol Depend; 2006 Sep; 84(1):102-13. PubMed ID: 16483730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users.
    Davis AK; Rosenberg H
    J Psychoactive Drugs; 2014; 46(2):154-61. PubMed ID: 25052792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users.
    Jones L; Reed P; Parrott A
    J Psychopharmacol; 2016 Dec; 30(12):1313-1320. PubMed ID: 27371497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission from drug dependence symptoms and drug use cessation among women drug users in puerto rico.
    Warner LA; Alegría M; Canino G
    Arch Gen Psychiatry; 2004 Oct; 61(10):1034-41. PubMed ID: 15466677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mephedrone: use, subjective effects and health risks.
    Winstock A; Mitcheson L; Ramsey J; Davies S; Puchnarewicz M; Marsden J
    Addiction; 2011 Nov; 106(11):1991-6. PubMed ID: 21592252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant Misuse of Sildenafil in London Nightclubs.
    Chan WL; Wood DM; Dargan PI
    Subst Use Misuse; 2015; 50(11):1390-4. PubMed ID: 26440912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent trends in the use of "club drugs": an Australian review.
    Degenhardt L; Copeland J; Dillon P
    Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.
    Wu LT; Parrott AC; Ringwalt CL; Patkar AA; Mannelli P; Blazer DG
    Addict Behav; 2009 Aug; 34(8):654-61. PubMed ID: 19361931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychostimulants].
    Pinto E; Pitchot W; Ansseau M
    Rev Med Liege; 2008; 63(5-6):411-6. PubMed ID: 18669213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory performance in abstinent 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
    Groth-Marnat G; Howchar H; Marsh A
    Percept Mot Skills; 2007 Feb; 104(1):43-55. PubMed ID: 17450963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The phenomenon of drug change in the interviews with injecting drug users].
    Rácz J; Csák R; Faragó R; Vadász V
    Psychiatr Hung; 2012; 27(1):29-47. PubMed ID: 22493147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study.
    Patel MM; Belson MG; Wright D; Lu H; Heninger M; Miller MA
    Resuscitation; 2005 Aug; 66(2):197-202. PubMed ID: 15963623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users.
    Hulka LM; Wagner M; Preller KH; Jenni D; Quednow BB
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):535-47. PubMed ID: 22704223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.